337 related articles for article (PubMed ID: 29131126)
41. Molecular and clinical characterization of H3 K27M-mutant "non-midline" glioblastoma: A case report and literature review.
Onishi S; Ohba S; Kuraoka K; Kurashige T; Sugiyama K; Yamasaki F
Neurocirugia (Astur : Engl Ed); 2022; 33(6):356-360. PubMed ID: 36333093
[TBL] [Abstract][Full Text] [Related]
42. Indolent presentation of a diffuse midline glioma, H3 K27-altered.
Damodharan S; Helgager J; Puccetti D
Childs Nerv Syst; 2023 Mar; 39(3):833-835. PubMed ID: 36094605
[TBL] [Abstract][Full Text] [Related]
43. Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain.
Su X; Chen N; Sun H; Liu Y; Yang X; Wang W; Zhang S; Tan Q; Su J; Gong Q; Yue Q
Neuro Oncol; 2020 Mar; 22(3):393-401. PubMed ID: 31563963
[TBL] [Abstract][Full Text] [Related]
44. Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas.
Raab P; Banan R; Akbarian A; Esmaeilzadeh M; Samii M; Samii A; Bertalanffy H; Lehmann U; Krauss JK; Lanfermann H; Hartmann C; Brüning R
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326549
[TBL] [Abstract][Full Text] [Related]
45. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.
Kleinschmidt-DeMasters BK; Mulcahy Levy JM
Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845
[TBL] [Abstract][Full Text] [Related]
46. Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient.
Cheng R; Li DP; Zhang N; Zhang JY; Zhang D; Liu TT; Yang J; Ge M
Front Surg; 2021; 8():616334. PubMed ID: 34222313
[No Abstract] [Full Text] [Related]
47. Clinicohistoradiological and surgical outcome in diffuse midline glioma.
Kumar Suman A; Bhattacharjee S; Uppin MS; Fathima ST
Childs Nerv Syst; 2024 Jan; 40(1):65-71. PubMed ID: 37644138
[TBL] [Abstract][Full Text] [Related]
48. Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.
D'Amico RS; Zanazzi G; Wu P; Canoll P; Bruce JN
J Neurooncol; 2018 Oct; 140(1):63-73. PubMed ID: 29992434
[TBL] [Abstract][Full Text] [Related]
49. Mosaic Pattern of H3 K27M-Mutant Protein Expression in a Diffuse Midline Glioma-A Diagnostic Dilemma for the Pathologist.
Narasimhaiah D; Thomas B; Abraham M; Poyuran R
J Neurosci Rural Pract; 2021 Jul; 12(3):596-598. PubMed ID: 34295118
[TBL] [Abstract][Full Text] [Related]
50. Pediatric spinal cord diffuse midline glioma with H3 K27M-alteration with leptomeningeal dissemination: a rare case with intracranial hypertension onset and no spinal cord-related symptom.
Liu Y; Sun P; Zhou M; Du J; Zeng G
Childs Nerv Syst; 2023 Jun; 39(6):1663-1666. PubMed ID: 36759369
[TBL] [Abstract][Full Text] [Related]
51. A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma.
Peng Y; Ren Y; Huang B; Tang J; Jv Y; Mao Q; Liu Y; Lei Y; Zhang Y
Sci Rep; 2023 Jun; 13(1):9970. PubMed ID: 37340065
[TBL] [Abstract][Full Text] [Related]
52. A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma.
Akinduro OO; Garcia DP; Higgins DMO; Vivas-Buitrago T; Jentoft M; Solomon DA; Daniels DJ; Pennington Z; Sherman WJ; Delgardo M; Bydon M; Kalani MA; Zanazzi G; Tsankova N; Bendok BR; McCormick PC; Sciubba DM; Lo SL; Clarke JL; Abode-Iyamah K; Quiñones-Hinojosa A
J Neurosurg Spine; 2021 Aug; 35(6):834-843. PubMed ID: 34416733
[TBL] [Abstract][Full Text] [Related]
53. Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.
Li Q; Dong F; Jiang B; Zhang M
Front Oncol; 2021; 11():646267. PubMed ID: 34109112
[TBL] [Abstract][Full Text] [Related]
54. Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System.
Yi S; Choi S; Shin DA; Kim DS; Choi J; Ha Y; Kim KN; Suh CO; Chang JH; Kim SH; Yoon DH
Neurosurgery; 2019 May; 84(5):1072-1081. PubMed ID: 29718432
[TBL] [Abstract][Full Text] [Related]
55. Detecting the H3F3A mutant allele found in high-grade pediatric glioma by real-time PCR.
Zhang R; Han J; Daniels D; Huang H; Zhang Z
J Neurooncol; 2016 Jan; 126(1):27-36. PubMed ID: 26376656
[TBL] [Abstract][Full Text] [Related]
56. Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients.
Jiang H; Yang K; Ren X; Cui Y; Li M; Lei Y; Lin S
Neuro Oncol; 2020 May; 22(5):e1-e9. PubMed ID: 31504810
[TBL] [Abstract][Full Text] [Related]
57. Histone H3 K27M mutations in adult cerebellar high-grade gliomas.
Nakata S; Nobusawa S; Yamazaki T; Osawa T; Horiguchi K; Hashiba Y; Yaoita H; Matsumura N; Ikota H; Hirato J; Yoshimoto Y; Yokoo H
Brain Tumor Pathol; 2017 Jul; 34(3):113-119. PubMed ID: 28547652
[TBL] [Abstract][Full Text] [Related]
58. Multimodal MR imaging signatures to identify brain diffuse midline gliomas with H3 K27M mutation.
Su X; Liu Y; Wang H; Chen N; Sun H; Yang X; Wang W; Zhang S; Wan X; Tan Q; Yue Q; Gong Q
Cancer Med; 2022 Feb; 11(4):1048-1058. PubMed ID: 34953060
[TBL] [Abstract][Full Text] [Related]
59. Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study.
Garibotto F; Madia F; Milanaccio C; Verrico A; Piccardo A; Tortora D; Piatelli G; Diana MC; Capra V; Garrè ML; Rossi A; Morana G
Front Oncol; 2020; 10():795. PubMed ID: 32582540
[No Abstract] [Full Text] [Related]
60. Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis.
Mariet C; Castel D; Grill J; Saffroy R; Dangouloff-Ros V; Boddaert N; Llamas-Guttierrez F; Chappé C; Puget S; Hasty L; Chrétien F; Métais A; Varlet P; Tauziède-Espariat A
Acta Neuropathol Commun; 2022 Sep; 10(1):137. PubMed ID: 36104744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
